Recent advances in systemic therapy: Advances in systemic therapy for HER2-positive metastatic breast cancer.
about
In silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancerSpontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer.Photodynamic Therapy with Hypericin Improved by Targeting HSP90 Associated Proteins.Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast CancerGenome-based risk prediction for early stage breast cancer.Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breastEvaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer.Tumor-Specific Systemic Treatment in Advanced Breast Cancer - How Long does it Make Sense?Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II studyCoexistence of benign phyllodes tumor and invasive ductal carcinoma in distinct breasts: case report.Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer.Effect of HER2 status on distant recurrence in early stage breast cancerHER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinomaThe expression and clinical significance of HERC4 in breast cancer.Herceptin resistance database for understanding mechanism of resistance in breast cancer patients.Added value of molecular targeted agents in oncology.Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma.Molecular-targeted nanotherapies in cancer: enabling treatment specificity.Clinical utility of gene-expression signatures in early stage breast cancer.Five-Year Disease-Free Follow-Up of a Borderline Breast Phyllodes Tumor in a 15-year-old Patient.Recent advances in systemic therapy for breast cancer: new technologies for a new era.Decreased total MKP-1 protein levels predict poor prognosis in breast cancer.Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers.
P2860
Q28303131-A602D6C3-0395-40D0-8FEE-CA4D99534BB7Q31132069-AA949348-3629-4DBF-A29B-7E78BA7EF8FAQ33765280-6DE2BC69-95E9-4204-A228-EAD7439B9D39Q34273051-D0AF4082-9AB1-42DA-AFFD-AF78E3771A7DQ34359289-3837DC8C-BB96-4354-ABF3-F4CC71E2F445Q34380366-D614FA3A-7641-4F19-9014-5AA77EEFF597Q34825969-E6A3C12F-4DF3-4214-A65F-16EDB0F966B3Q34870267-B0B4E2A0-4E13-45EA-B2A1-3179D3A49078Q35114038-0A34DF20-43CF-4135-8F7F-AF00F4E5A8C3Q36167858-6189F999-7B9A-443D-AE8E-55FCE2ABBF98Q36230542-FB6BBE2D-258D-490D-9478-E87BADFC4356Q36530791-0D875F0C-F43E-4FC4-ACEA-D4D98E71DB2AQ37295329-6A819523-E0C0-4D32-A243-7A78F55F03B9Q37322118-D6E5B579-F6C6-4036-AFCD-50AFDF5F8F47Q37666730-E77913F8-3AAE-470C-96F0-26482B31A5FAQ37837267-457021E6-7B89-4C51-90C6-E748421DFD11Q37941807-AAAE4531-5957-41BA-B6BE-3C3B01A5D963Q37954497-E939AD9D-668F-4BA9-9E48-2AD2C7385093Q38754717-5EC41CA8-0076-4552-BD23-1EEDD40F41C0Q42316320-D17DFAFE-E9DB-4B56-AC9F-AFC765838660Q42563464-57DD7949-06A6-44BA-89AF-21DF08A12F0AQ53171569-1A10E4B8-A921-4DCE-9FF0-ACFCDAC00C19Q55078620-37669A0B-AC3D-4D7D-9912-7E22C78867F1
P2860
Recent advances in systemic therapy: Advances in systemic therapy for HER2-positive metastatic breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent advances in systemic th ...... tive metastatic breast cancer.
@en
Recent advances in systemic th ...... tive metastatic breast cancer.
@nl
type
label
Recent advances in systemic th ...... tive metastatic breast cancer.
@en
Recent advances in systemic th ...... tive metastatic breast cancer.
@nl
prefLabel
Recent advances in systemic th ...... tive metastatic breast cancer.
@en
Recent advances in systemic th ...... tive metastatic breast cancer.
@nl
P2093
P2860
P921
P356
P1476
Recent advances in systemic th ...... tive metastatic breast cancer.
@en
P2093
Francisco J Esteva
Francisco Zambrana
Phuong Khanh H Morrow
P2860
P2888
P356
10.1186/BCR2324
P577
2009-07-15T00:00:00Z
P5875
P6179
1047856474